hexenal for a Michael addition reaction, the
product of which is aromatized to form CPH
(Fig. 4B).
CPH is responsible forEmpoascaresistance
To test whether CPH is responsible forEmpoasca
resistance, we fedE. decipienswith physiolog-
ically relevant concentrations of 1mM (esti-
mated from field-collected elicited leaves) of
NMR-confirmed CPH in diets containing 10%
glucose in vitro. After 6 hours of feeding, the
CPH treatment caused almost 100% mortal-
ity ofE. decipiens, in contrast to leafhopper
growth on control diets (P=3×10−^8 ; Student’s
ttest) (Fig. 4C). We further silencedNaAT1
expression inN. attenuataplants using VIGS,
which disrupted the production of both CP
and CPH ( 14 ) (Fig. 3D). In vivo choice assays
revealed thatNaAT1-silenced plants received
significantly moreEmpoascadamage andhigherEmpoascanumbers than EV plants
(Fig. 4C). Similarly, silencing eitherNaPPO1
orNaPPO2in plants abolished only the accu-
mulation of CPH in plants, without significant
alterations in other phenolamide pools (Fig. 3D
and fig. S16), and resulted in a clearEmpoasca
feeding preference (P= 0.013 andP= 0.022,
respectively) and greaterEmpoascadamage
(P= 0.008 andP= 0.008, respectively) com-
pared with that observed in EV plants (Fig. 4C).Baiet al.,Science 375 , eabm2948 (2022) 4 February 2022 7of9
Fig. 4. Structural elucida-
tion, biosynthesis,
function, and engineering
ofm/z347.19 in vitro
and in planta.(A) In vitro
enzymatic assays for
m/z347.19 production
revealed that either NaPPO1
or NaPPO2 can catalyze
the condensation of CP and
(Z)-3-hexenal (Z3H) to
formm/z347.19. Extracted
ion chromatograms (EICs)
for doubly charged CP
dimer (m/z250.13) and
m/z347.19 inE. coliÐ
expressing NaPPO1 and
NaPPO2 with CP and
Z3H or (E)-2-hexenal (E2H).
Compounds 1, 2, 3, and
4 denote isomers of
CP dimer; compounds
5 and 6 denote isomers of
m/z347.19. (B) Proposed
enzymatic reactions
mediated by NaPPO1 or
NaPPO2 form/z347.19
synthesis: NaPPO1/2
oxidize CP to caffeoyl
quinone putrescine and
activate Z3H for the Michael
addition reaction, followed
by aromatization to yield
m/z347.19. (C) Mortality
rates of in vitroEmpoasca
nonchoice assays (n=4,25
Empoascaleafhoppers
per replicate) in which
Empoascawere fed for
6 hours either with 1mMm/z
347.19 synthesized by using
NaPPO1/2, CP, and Z3H
and diluted in 10% glucose
solution or with 10%
glucose as control (top).
Empoascain planta choice assays (n= 8) conducted with VIGS plants of EV, PPO1, PPO2, and AT1 (bottom). (D) Genes involved in the biosynthesis ofm/z347.19.
(E) Engineering of biosynthetic pathways for the production ofm/z347.19 in plants. NeitherV. fabanor the wild tomatoS. chilenseaccumulatem/z347.19 in
response to elicitation.S. chilenseaccumulates CP after MeJA elicitation, whereasV. fabadoes not (inserted heatmaps).S. chilensecan be engineered to producem/z
347.19 by expressing NaPPO1, NaPPO2, and NaBBL2 with Z3H infiltrations in MeJA-elicitedS. chilenseleaves.m/z347.19 accumulates only inS. chilenseexpressing
NaPPO1/2 together with NaBBL2, but not NaPPO1/2 alone.V. fabacan be engineered to producem/z347.19 by expressing NaPPO1, NaPPO2, and NaBBL2 with
Z3H and CP infiltrations in leaves. Also shown are mortality rates of in vivoEmpoascafeeding assays (n= 4, 25Empoascaleafhoppers per replicate) in which
Empoascawere fed for 10 hours on leaves of reconstitutedS. chilenseandV. faba, respectively.
ABD10075
50250Mortality (%)***10%Glucose10%Glucose
+m/z 347.19HOHON
HO
NH 2 OON
HO
NaPPO1/NaPPO2 NH^2OHON
HNH 2OHOHHOHON
HO
NH 2O
HMichael additionAromatizationoxidation
quinoneZ3HN-CaffeoylputrescineNaPPO1/NaPPO2(5, 6) m/z 347.19O024EV PPO1 PPO2 AT1Damage area (%)baaa0.02.55.07.5Empoascanumber
ba a aCPhenylalanine
ONH 2OHCaffeoyl-CoA
CoAO
SOHOHm/z 347.19
O
NH NH^2OHOHCH 3O
O
NH
NH 2OHOHNaPALNaC4H Na4CLNaHCTNaC3HNaHCTNaAT1 NaPPO1NaPPO2NaBBL2Z3HNaODC NaHPLNH 2
H 2 NPhenylpropanoid pathway Polyamine pathway GLV pathway Present studyPutrescineN-CaffeoylputrescineE
Solanum
chilense3 4 502468Intensity (x103 )m/z 347.19Retention time (min)NaPPO1&2
+NaBBL2+Z3H
NaPPO1&2+Z3H
EV+Z3HEICm/z 347.19m/z 347.19CPMeJACAbsent Present
Untransformed WT1 2 3 4 5 60.00.51.01.52.02.53.0Intensity (x104 )1 2 34 5 6m/z 250.13 m/z 347.19[M+2H]2+ [M+H]+NaPPO1+CP+Z3H
NaPPO2+CP+Z3H
NaPPO1+CP+E2H
NaPPO2+CP+E2H
CP+Z3Hm/z 250.13
m/z 347.19EICRetention time (min)Vicia faba02004006008004 5
Retention time (min)IntensityEV+CP+Z3HNaPPO1&2
+NaBBL2+CP+Z3HEICm/z 347.19 m/z 347.19m/z 347.19CPMeJACAbsent PresentNaPPO1&2+NaBBL2+CPUntransformed WT0255075100TreatmentMortality (%)0255075100TreatmentMortality (%)EV+Z3H
NaPPO1+NaBBL2+Z3H
NaPPO2+NaBBL2+Z3HEV+Z3H
NaPPO1+NaBBL2+CP+Z3H
NaPPO2+NaBBL2+CP+Z3HEV+CPb ba a ab bEV+Z3HNaPPO1
+NaBBL2+Z3H
NaPPO2
+NaBBL2+Z3HEV+Z3HNaPPO1
+NaBBL2
+CP+Z3HNaPPO2
+NaBBL2+CP+Z3H
EV+CPOORESEARCH | RESEARCH ARTICLE